Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
MUC4 |
mucin 4, cell surface associated |
3q29 |
2(0/2/0)
|
CDV3 |
CDV3 homolog (mouse) |
3q22.1 |
1(0/0/1)
|
SNX4 |
sorting nexin 4 |
3q21.2 |
1(0/0/1)
|
TRH |
thyrotropin-releasing hormone |
3q13.3-q21 |
1(1/0/0)
|
LAMP3 |
lysosomal-associated membrane protein 3 |
3q26.3-q27 |
1(1/0/0)
|
ITGA9 |
integrin, alpha 9 |
3p21.3 |
1(1/0/0)
|
TRAIP |
TRAF interacting protein |
3p21.31 |
1(0/0/1)
|
VEZF1P1 |
vascular endothelial zinc finger 1 pseudogene 1 |
3q29 |
1(0/1/0)
|
OPA1 |
optic atrophy 1 (autosomal dominant) |
3q29 |
1(0/1/0)
|
TFRC |
transferrin receptor |
3q29 |
1(0/1/0)
|
DLG1 |
discs, large homolog 1 (Drosophila) |
3q29 |
2(1/1/0)
|
LMOD3 |
leiomodin 3 (fetal) |
3p14.1 |
1(0/1/0)
|
TM4SF19 |
transmembrane 4 L six family member 19 |
3q29 |
1(0/1/0)
|
GNL3 |
guanine nucleotide binding protein-like 3 (nucleolar) |
3p21.1 |
2(2/0/0)
|
GABRR3 |
gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene) |
3q11.2 |
1(1/0/0)
|
LSG1 |
large 60S subunit nuclear export GTPase 1 |
3q29 |
1(0/1/0)
|
PROK2 |
prokineticin 2 |
3p21.1 |
1(0/1/0)
|
SYN2 |
synapsin II |
3p25.2 |
1(0/1/0)
|
CMTM8 |
CKLF-like MARVEL transmembrane domain containing 8 |
3p22.2 |
2(1/1/0)
|
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
3p24-p23 |
1(0/1/0)
|
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
3p12.2 |
1(0/1/0)
|
CRBN |
cereblon |
3p26.3 |
1(1/0/0)
|
NCBP2 |
nuclear cap binding protein subunit 2, 20kDa |
3q29 |
1(0/1/0)
|
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
3p12.3 |
1(0/1/0)
|
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
3p12 |
1(1/0/0)
|
FGF12 |
fibroblast growth factor 12 |
3q28 |
1(0/1/0)
|
CHL1 |
cell adhesion molecule L1-like |
3p26 |
1(1/0/0)
|
XXYLT1 |
xyloside xylosyltransferase 1 |
3q29 |
2(0/2/0)
|
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
1(1/0/0)
|
CCK |
cholecystokinin |
3p22.1 |
2(0/1/1)
|
ITIH1 |
inter-alpha-trypsin inhibitor heavy chain 1 |
3p21.1 |
1(1/0/0)
|
GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
FYTTD1 |
forty-two-three domain containing 1 |
3q29 |
1(0/1/0)
|
NEK4 |
NIMA-related kinase 4 |
3p21.1 |
1(1/0/0)
|
PPP1R2 |
protein phosphatase 1, regulatory (inhibitor) subunit 2 |
3q29 |
1(0/1/0)
|
PLCL2 |
phospholipase C-like 2 |
3p24.3 |
1(0/1/0)
|
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
3p21.1 |
3(3/0/0)
|
CNTN4 |
contactin 4 |
3p26.3 |
1(1/0/0)
|
GRM2 |
glutamate receptor, metabotropic 2 |
3p21.2 |
1(0/1/0)
|
UBE2E2 |
ubiquitin-conjugating enzyme E2E 2 |
3p24.2 |
1(0/1/0)
|
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
3q29 |
2(1/1/0)
|
LMLN |
leishmanolysin-like (metallopeptidase M8 family) |
3q29 |
1(0/1/0)
|
SST |
somatostatin |
3q28 |
1(0/1/0)
|
ACAP2 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 |
3q29 |
1(0/1/0)
|
ATP1B3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
3q23 |
1(0/1/0)
|
ATP13A4 |
ATPase type 13A4 |
3q29 |
1(0/1/0)
|
RPSAP30 |
ribosomal protein SA pseudogene 30 |
3q29 |
1(0/1/0)
|
OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
WDR53 |
WD repeat domain 53 |
3q29 |
1(0/1/0)
|
LOC727978 |
mucin-5AC-like |
3q29 |
1(0/1/0)
|
DPPA2P3 |
developmental pluripotency associated 2 pseudogene 3 |
3q29 |
1(0/1/0)
|
LOC220729 |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp) pseudogene |
3q29 |
1(1/0/0)
|
ZXDC |
ZXD family zinc finger C |
3q21.3 |
1(0/1/0)
|
RAD18 |
RAD18 E3 ubiquitin protein ligase |
3p25.3 |
1(0/0/1)
|
KCNMB2 |
potassium channel subfamily M regulatory beta subunit 2 |
3q26.32 |
1(1/0/0)
|
ZNF385D |
zinc finger protein 385D |
3p24.3 |
1(0/1/0)
|
FAM43A |
family with sequence similarity 43, member A |
3q29 |
1(0/1/0)
|
CPN2 |
carboxypeptidase N, polypeptide 2 |
3q29 |
1(1/0/0)
|
CNTN6 |
contactin 6 |
3p26.3 |
1(1/0/0)
|
MBNL1 |
muscleblind-like splicing regulator 1 |
3q25 |
1(1/0/0)
|
TRANK1 |
tetratricopeptide repeat and ankyrin repeat containing 1 |
3p22.2 |
5(2/1/2)
|
MB21D2 |
Mab-21 domain containing 2 |
3q28-q29 |
1(0/1/0)
|
HES1 |
hes family bHLH transcription factor 1 |
3q28-q29 |
1(0/1/0)
|
SMCO1 |
single-pass membrane protein with coiled-coil domains 1 |
3q29 |
1(0/1/0)
|
FBLN2 |
fibulin 2 |
3p25-p24 |
1(0/0/1)
|
CLDN16 |
claudin 16 |
3q28 |
1(0/1/0)
|
GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
ERC2 |
ELKS/RAB6-interacting/CAST family member 2 |
3p14.3 |
1(0/0/1)
|
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
3q26 |
1(1/0/0)
|
APOD |
apolipoprotein D |
3q29 |
1(0/1/0)
|
MED12L |
mediator complex subunit 12-like |
3q25.1 |
1(1/0/0)
|
TCTEX1D2 |
Tctex1 domain containing 2 |
3q29 |
1(0/1/0)
|
P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
3q24 |
1(1/0/0)
|
PBRM1 |
polybromo 1 |
3p21 |
5(4/0/1)
|
LRRC15 |
leucine rich repeat containing 15 |
3q29 |
1(0/1/0)
|
ZBTB20 |
zinc finger and BTB domain containing 20 |
3q13.2 |
1(0/1/0)
|
GLT8D1 |
glycosyltransferase 8 domain containing 1 |
3p21.1 |
1(1/0/0)
|
TNK2 |
tyrosine kinase, non-receptor, 2 |
3q29 |
1(0/1/0)
|
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
3p14.1 |
1(1/0/0)
|
UBXN7 |
UBX domain protein 7 |
3q29 |
1(0/1/0)
|
TMEM108 |
transmembrane protein 108 |
3q22.1 |
1(1/0/0)
|
POMGNT2 |
protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) |
3p22.1 |
1(0/0/1)
|
EGFEM1P |
EGF-like and EMI domain containing 1, pseudogene |
3q26.2 |
1(0/1/0)
|
ZDHHC19 |
zinc finger, DHHC-type containing 19 |
3q29 |
1(0/1/0)
|
GPR87 |
G protein-coupled receptor 87 |
3q24 |
1(1/0/0)
|
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
CADM2 |
cell adhesion molecule 2 |
3p12.2 |
1(0/1/0)
|
CCDC50 |
coiled-coil domain containing 50 |
3q28 |
2(1/1/0)
|
DOCK3 |
dedicator of cytokinesis 3 |
3p21 |
1(0/1/0)
|
VEPH1 |
ventricular zone expressed PH domain-containing 1 |
3q24-q25 |
1(1/0/0)
|